Older adults dealing with depression often face compounding challenges when they become intensely fearful of their own ...

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...

Major depressive disorder (MDD) is a disturbance of mood that may have persistent and long-term consequences impacting patients’ overall level of functioning and quality of life. 1 Historically, ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

An analysis of 35,000 Canadians shows that rising cannabis use and worsening mental-health symptoms are increasingly ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

A new study suggests wrist-worn sleep trackers may help predict depression relapse weeks early—explore what this means for ...

—Researchers recently examined the impact of depressive symptoms, as measured by the 21-item Beck Depression Inventory, on adherence to therapy using correlation, network analysis, and linear ...

Johnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants alone. The ...

Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions ...

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...